Coronavirus 'super-spreaders' named as restaurants, fast food and hotels: Study
Scientists are examining the potential of a COVID-19 resurgence and how “super-spreader” businesses could risk contributing to the transmission of the coronavirus as states reopen from pandemic shutdowns.
Quest Diagnostics launches coronavirus testing for employees returning to work
The “return to work services” provide employers access to its COVID-19 antibody testing.
Half of Americans would get a coronavirus vaccine: Poll
The poll, released Wednesday, found 31% simply weren't sure if they'd get vaccinated. Another 1 in 5 said they'd refuse.
Coronavirus inspires New England Patriots CEO to help Americans in need
Robert Kraft on his coronavirus relief efforts
Coronavirus ID wristbands, buttons could aid post-pandemic social-distancing
The C19 I.D. Project launched color-coded bracelets which will hopefully reduce people's anxiety in a post-coronavirus world.
Pence thanks Americans for staying socially distant
Pence on affordable insulin, treatment, coronavirus
Trump: We are pursuing vaccines at record speed
Trump touts how premiums are now affordable for millions of Americans
Health care CEOs thank Trump for helping to cap insulin prices
Health care CEOs say insulin should be available to anyone who needs it
Trump announces insulin price cap for senior citizens
Trump touts massive cuts in insulin prices for affected Americans
New Rochelle, NY, enters phase one of reopening
Noam Bramson on his city's current status
What three ETFs are equal to the Triple Crown?
Expert shares which ETFs are doing well during coronavirus
Japan's coronavirus approach used common sense: Sen. Mike Braun
Sen. Braun compares and contrasts the coronavirus response in Japan versus the U.S.
Novavax 'confident' in scaling up to 100M vaccine doses by end of year: R&D chief
Maryland-based Novavax just began dosing for the Phase 1 clinical trial in Australia.
Varney: America's 'mood' changing from coronavirus lockdown to break out
FOX Business' Stuart Varney during his latest "My Take” argues Americans and markets are becoming more positive about the coronavirus.
100M doses of coronavirus vaccine can be ready by end of year: Novavax exec
Gregory Glenn on Novavax coronavirus vaccine
Coronavirus testing not needed for every American: LabCorp CEO
LabCorp has conducted over 2.2 million PCR tests for coronavirus and plans to scale up to 150,000 tests a day by mid-June.
UVC lamps could zap coronavirus in public spaces
Grady Trimble on UV lights, coronavirus
US has the coronavirus testing ‘that we need’: LabCorp CEO
Adam Schechter on coronavirus, LabCorp
Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group
If Phase 1 is successful, Novavax will follow up with Phase 2 in multiple countries, including the U.S.
WHO pauses coronavirus hydroxychloroquine trial over safety concerns
The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the malaria drug U.S. President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.